Phenethyl bromide → 2,4-Dioxo-5-phenyl-1-(2-phenylethyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine
Reaction equation
[H-].[Na+].[O:3]=[C:4]1[NH:10][C:9]2[CH:11]=[CH:12][CH:13]=[CH:14][C:8]=2[N:7]([C:15]2[CH:20]=[CH:19][CH:18]=[CH:17][CH:16]=2)[C:6](=[O:21])[CH2:5]1.[C:22]1([CH2:28][CH2:29]Br)[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=1>CN(C=O)C.CC(=O)OCC>[O:3]=[C:4]1[N:10]([CH2:29][CH2:28][C:22]2[CH:27]=[CH:26][CH:25]=[CH:24][CH:23]=2)[C:9]2[CH:11]=[CH:12][CH:13]=[CH:14][C:8]=2[N:7]([C:15]2[CH:16]=[CH:17][CH:18]=[CH:19][CH:20]=2)[C:6](=[O:21])[CH2:5]1Participants
6
Procedure
Sodium hydride 80% dispersion in oil (0.13 g) was added portionwise to a solution of the 2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine (compound a) (1 g) in DMF (18 ml) previously cooled at 0°. The reaction was stirred for 20 min at 0°, then a solution of 2-phenylethyl bromide (0.85 ml) in DMF (2 ml) was added dropwise, the mixture was stirred at 23° for 15 h, then diluted with EA (80 ml) and washed with brine (3×100 ml), dried and concentrated "in vacuo". The crude product was purified by flash chromatography (eluting with CH-EA 1:1) to give the title compound as a white powder (0.85 g). T.l.c. CH-EA (1:1), Rf =0.27.
Workup
- temperaturepreviously cooled at 0°
- stirringthe mixture was stirred at 23° for 15 h
- washwashed with brine (3×100 ml)
- customdried
- concentrationconcentrated "in vacuo"
- customThe crude product was purified by flash chromatography (eluting with CH-EA 1:1)
Sources & evidence
- ORD record
- ord-2a403e99efa64ba29e5dd117948b6de8
- Source dataset
- uspto-grants-1997_06
- Patent number
- US05637697
Reaction notes
Loading…